๐Ÿ”Ž Trials Near Me

Home โ€บ Lung Cancer

Lung Cancer clinical trials recruiting in the U.S.

347 studies for Lung Cancer are recruiting participants at sites across the United States.

Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.

Cities with the most studies

By state

Recently updated studies

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07519655

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

RecruitingObservational study
Ages 3 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT01441089

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07099898

Collection of Blood From Patients With Cancer

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT00034216

SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier

RecruitingObservational studyHealthy volunteers welcome
Ages 21 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07460440

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07286149

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07489066

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06172478

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT06855524

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 24, 2026 ยท NCT04181060

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

RecruitingPhase 3
Ages 70 and older ยท All sexes ยท Updated Sep 24, 2026 ยท NCT06096844

A Registry for People With Lung Cancer

RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Sep 24, 2026 ยท NCT06424327

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

RecruitingPhase 2
Ages 18 to 95 ยท All sexes ยท Updated Sep 23, 2026 ยท NCT05061550

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

RecruitingObservational study
Ages 2 to 120 ยท All sexes ยท Updated Sep 23, 2026 ยท NCT00242723

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.